Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Ageing

A midlife longevity drug?

The small molecule rapamycin, already approved for clinical use for various human disorders, has been found to significantly increase lifespan in mice. Is this a step towards an anti-ageing drug for people?

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Rapa Nui and rapamycin.

H. KANUS/SPL

References

  1. Harrison, D. E. et al. Nature 460, 392–395 (2009).

    Article  CAS  ADS  Google Scholar 

  2. Jia, K., Chen, D. & Riddle, D. L. Development 131, 3897–3906 (2004).

    Article  CAS  Google Scholar 

  3. Kaeberlein, M. et al. Science 310, 1193–1196 (2005).

    Article  CAS  ADS  Google Scholar 

  4. Kapahi, P. et al. Curr. Biol. 14, 885–890 (2004).

    Article  CAS  Google Scholar 

  5. Powers, R. W. 3rd, Kaeberlein, M., Caldwell, S. D., Kennedy, B. K. & Fields, S. Genes Dev. 20, 174–184 (2006).

    Article  CAS  Google Scholar 

  6. Vellai, T. et al. Nature 426, 620 (2003).

    Article  CAS  ADS  Google Scholar 

  7. Stanfel, M. N., Shamieh, L. S., Kaeberlein, M. & Kennedy, B. K. Biochim. Biophys. Acta advance online publication doi:10.1016/j.bbagen.2009.06.007 (2009).

  8. Smith, E. D. et al. Genome Res. 18, 564–570 (2008).

    Article  CAS  Google Scholar 

  9. Steffen, K. K. et al. Cell 133, 292–302 (2008).

    Article  CAS  Google Scholar 

  10. Hansen, M. et al. PLoS Genet. 4, e24 (2008).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

M.K. and B.K.K. have patents pending for high-throughput methods for measuring lifespan in yeast.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaeberlein, M., Kennedy, B. A midlife longevity drug?. Nature 460, 331–332 (2009). https://doi.org/10.1038/460331a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/460331a

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing